Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-let-7a-3p ABCA1 0.1 0.64662 -0.05 0.8308 mirMAP; miRNATAP -0.39 0 NA
2 hsa-let-7a-3p ABCC9 0.1 0.64662 -0.58 0.0487 mirMAP -0.8 0 NA
3 hsa-let-7a-3p ABCD2 0.1 0.64662 -0.21 0.52359 mirMAP -0.51 5.0E-5 NA
4 hsa-let-7a-3p ABI3BP 0.1 0.64662 -0.52 0.15667 miRNATAP -0.62 2.0E-5 NA
5 hsa-let-7a-3p ACVR1 0.1 0.64662 0.01 0.92099 MirTarget; miRNATAP -0.12 0.00024 NA
6 hsa-let-7a-3p ADAM23 0.1 0.64662 -0.79 0.03549 mirMAP -0.96 0 NA
7 hsa-let-7a-3p ADAMTS5 0.1 0.64662 -0.21 0.26397 mirMAP -0.36 0 NA
8 hsa-let-7a-3p ADAMTSL3 0.1 0.64662 -0.46 0.25267 MirTarget -1.14 0 NA
9 hsa-let-7a-3p ADCYAP1 0.1 0.64662 -0.2 0.67185 miRNATAP -1.12 0 NA
10 hsa-let-7a-3p ADD2 0.1 0.64662 -0.98 0.01735 mirMAP -0.74 0 NA
11 hsa-let-7a-3p AFF2 0.1 0.64662 -0.19 0.58722 mirMAP -0.35 0.012 NA
12 hsa-let-7a-3p AFF3 0.1 0.64662 -0.89 0.00696 MirTarget -0.46 0.00048 NA
13 hsa-let-7a-3p AKAP12 0.1 0.64662 -0.67 0.05157 miRNATAP -0.88 0 NA
14 hsa-miR-106a-5p AKT3 0.54 0.00783 -0.59 0.01641 miRNATAP -0.55 0 NA
15 hsa-miR-106b-5p AKT3 0.28 0.27737 -0.59 0.01641 miRNATAP -0.91 0 NA
16 hsa-miR-107 AKT3 0.03 0.92021 -0.59 0.01641 PITA; miRanda -0.55 0.00017 NA
17 hsa-miR-1275 AKT3 0.83 0.00691 -0.59 0.01641 PITA -0.27 0 NA
18 hsa-miR-140-5p AKT3 0.06 0.76321 -0.59 0.01641 miRanda -0.29 0.02297 NA
19 hsa-miR-142-3p AKT3 0.14 0.67255 -0.59 0.01641 miRanda -0.2 0.00627 NA
20 hsa-miR-15a-5p AKT3 0.21 0.34754 -0.59 0.01641 miRNAWalker2 validate; miRTarBase; miRNATAP -0.72 0 NA
21 hsa-miR-15b-5p AKT3 0.1 0.68086 -0.59 0.01641 miRNATAP -0.67 0 NA
22 hsa-miR-16-5p AKT3 0.15 0.59028 -0.59 0.01641 miRNAWalker2 validate; miRTarBase; miRNATAP -0.75 0 NA
23 hsa-miR-17-3p AKT3 0.43 0.11212 -0.59 0.01641 miRNATAP -0.52 0 NA
24 hsa-miR-17-5p AKT3 0.65 0.03209 -0.59 0.01641 TargetScan; miRNATAP -0.63 0 NA
25 hsa-miR-181b-5p AKT3 0.11 0.64918 -0.59 0.01641 miRNATAP -0.27 0.00963 NA
26 hsa-miR-20a-5p AKT3 0.58 0.05042 -0.59 0.01641 miRNATAP -0.53 0 NA
27 hsa-miR-28-3p AKT3 -0.01 0.98438 -0.59 0.01641 miRNATAP -0.52 0.00719 NA
28 hsa-miR-29a-3p AKT3 0.42 0.21085 -0.59 0.01641 miRNATAP -0.81 0 NA
29 hsa-miR-29b-3p AKT3 0.58 0.04258 -0.59 0.01641 miRNATAP -0.68 0 26512921 MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3
30 hsa-miR-32-3p AKT3 0.33 0.22485 -0.59 0.01641 mirMAP -0.56 0 NA
31 hsa-miR-320a AKT3 0.04 0.86884 -0.59 0.01641 PITA; miRanda; miRNATAP -0.33 0.00138 NA
32 hsa-miR-320b AKT3 0.05 0.83543 -0.59 0.01641 PITA; miRanda; miRNATAP -0.25 0.00855 NA
33 hsa-miR-320c AKT3 0.13 0.61008 -0.59 0.01641 PITA; miRanda; miRNATAP -0.17 0.01525 NA
34 hsa-miR-335-3p AKT3 0.68 0.00891 -0.59 0.01641 mirMAP -0.58 0 NA
35 hsa-miR-33a-3p AKT3 0.08 0.72668 -0.59 0.01641 mirMAP -0.49 0 NA
36 hsa-miR-340-5p AKT3 0.04 0.84726 -0.59 0.01641 mirMAP -0.28 0.006 NA
37 hsa-miR-362-3p AKT3 0.11 0.64379 -0.59 0.01641 miRanda -0.42 0 NA
38 hsa-miR-362-5p AKT3 0.51 0.05114 -0.59 0.01641 PITA; TargetScan; miRNATAP -0.52 0 NA
39 hsa-miR-369-3p AKT3 0.14 0.49946 -0.59 0.01641 mirMAP -0.23 0.00901 NA
40 hsa-miR-374a-5p AKT3 0.32 0.07709 -0.59 0.01641 mirMAP -0.58 0 NA
41 hsa-miR-374b-5p AKT3 0.42 0.03682 -0.59 0.01641 mirMAP -0.68 0 NA
42 hsa-miR-421 AKT3 0.48 0.01756 -0.59 0.01641 miRanda; mirMAP -0.46 0 NA
43 hsa-miR-424-5p AKT3 0.36 0.2087 -0.59 0.01641 miRNATAP -0.24 0.00104 26315541 Silencing Akt3 and E2F3 by siRNA pheno-copied the effect of ectopic miR-424 on HCC growth; Whereas overexpression of Akt3 and E2F3 attenuated the effect of miR-424 on HCC growth
44 hsa-miR-501-3p AKT3 0.23 0.34115 -0.59 0.01641 miRNATAP -0.5 0 NA
45 hsa-miR-502-3p AKT3 0.22 0.26772 -0.59 0.01641 miRNATAP -0.64 0 NA
46 hsa-miR-502-5p AKT3 0.06 0.78657 -0.59 0.01641 PITA; miRNATAP -0.41 0 NA
47 hsa-miR-505-3p AKT3 0.31 0.12792 -0.59 0.01641 mirMAP -0.77 0 22051041 We also find that Akt3 correlate inversely with miR-505 modulates drug sensitivity in MCF7-ADR
48 hsa-miR-539-5p AKT3 0.26 0.1605 -0.59 0.01641 mirMAP; miRNATAP -0.19 0.0467 NA
49 hsa-miR-548o-3p AKT3 0.29 0.19181 -0.59 0.01641 mirMAP -0.31 8.0E-5 NA
50 hsa-miR-577 AKT3 -0.13 0.72426 -0.59 0.01641 mirMAP -0.38 0 NA
51 hsa-miR-663b AKT3 0.42 0.1768 -0.59 0.01641 PITA -0.25 1.0E-5 NA
52 hsa-miR-769-5p AKT3 0.35 0.04592 -0.59 0.01641 PITA; miRNATAP -0.84 0 NA
53 hsa-miR-93-5p AKT3 0.24 0.47849 -0.59 0.01641 miRNATAP -0.76 0 NA
54 hsa-let-7a-3p ALDH1L2 0.1 0.64662 0.05 0.87117 MirTarget -0.5 0 NA
55 hsa-let-7a-3p AMIGO2 0.1 0.64662 -0.38 0.13272 MirTarget; mirMAP -0.39 5.0E-5 NA
56 hsa-let-7a-3p AMOTL1 0.1 0.64662 -0.76 0.00615 mirMAP -0.64 0 NA
57 hsa-let-7a-3p ANKRD50 0.1 0.64662 -0.03 0.85777 mirMAP -0.19 4.0E-5 NA
58 hsa-let-7a-3p ANO5 0.1 0.64662 -0.63 0.19521 mirMAP -0.59 0.00256 NA
59 hsa-let-7a-3p ANTXR1 0.1 0.64662 -0.67 0.04479 mirMAP; miRNATAP -0.79 0 NA
60 hsa-let-7a-3p AQP9 0.1 0.64662 -0.94 0.0441 MirTarget -0.89 0 NA
61 hsa-let-7a-3p ARHGAP20 0.1 0.64662 -1 0.00162 MirTarget; miRNATAP -0.61 0 NA
62 hsa-let-7a-3p ARHGAP28 0.1 0.64662 -0.24 0.37339 mirMAP -0.39 0.00025 NA
63 hsa-let-7a-3p ARHGAP29 0.1 0.64662 -0.14 0.48042 mirMAP -0.27 0.00025 NA
64 hsa-let-7a-3p ARL10 0.1 0.64662 -0.13 0.63188 mirMAP -0.55 0 NA
65 hsa-let-7a-3p ARSB 0.1 0.64662 -0.61 0.0002 mirMAP -0.17 0.00258 NA
66 hsa-let-7a-3p ASAH1 0.1 0.64662 -0.22 0.24281 MirTarget -0.14 0.00225 NA
67 hsa-let-7a-3p ASAP1 0.1 0.64662 0.16 0.3669 mirMAP -0.19 0.0006 NA
68 hsa-let-7a-3p ASXL2 0.1 0.64662 -0.01 0.96811 mirMAP; miRNATAP -0.18 0.00081 NA
69 hsa-let-7a-3p ATE1 0.1 0.64662 0.01 0.94513 mirMAP -0.13 0.00265 NA
70 hsa-let-7a-3p ATF2 0.1 0.64662 0.01 0.9159 MirTarget; mirMAP; miRNATAP -0.15 4.0E-5 NA
71 hsa-let-7a-3p ATP6AP2 0.1 0.64662 0.15 0.44442 mirMAP -0.13 0.00027 NA
72 hsa-let-7a-3p ATRN 0.1 0.64662 -0.04 0.82833 miRNATAP -0.26 8.0E-5 NA
73 hsa-let-7a-3p ATRX 0.1 0.64662 0.19 0.22771 MirTarget; miRNATAP -0.13 0.00051 NA
74 hsa-let-7a-3p B3GALNT1 0.1 0.64662 -0.27 0.30827 mirMAP -0.37 0.00031 NA
75 hsa-let-7a-3p BAG4 0.1 0.64662 -0.13 0.39218 mirMAP -0.2 0.00021 NA
76 hsa-let-7a-3p BASP1 0.1 0.64662 -0.55 0.03174 miRNATAP -0.46 0 NA
77 hsa-let-7a-3p BCL6 0.1 0.64662 -0.43 0.02067 miRNATAP -0.17 0.00802 NA
78 hsa-let-7a-3p BDNF 0.1 0.64662 0.08 0.7348 MirTarget; miRNATAP -0.24 0.00935 NA
79 hsa-let-7a-3p BEND4 0.1 0.64662 -0.57 0.13158 mirMAP -0.41 0.00473 NA
80 hsa-let-7a-3p BEND6 0.1 0.64662 -0.57 0.06554 mirMAP -0.77 0 NA
81 hsa-let-7a-3p BICD2 0.1 0.64662 -0.03 0.8456 mirMAP -0.1 0.00472 NA
82 hsa-let-7a-3p BMP2K 0.1 0.64662 -0.16 0.18742 mirMAP -0.17 6.0E-5 NA
83 hsa-let-7a-3p BMP3 0.1 0.64662 -0.16 0.77953 MirTarget; mirMAP -0.82 0.00029 NA
84 hsa-let-7a-3p BMPR1B 0.1 0.64662 -1.56 0.00021 miRNATAP -0.61 0.00028 NA
85 hsa-let-7a-3p BMPR2 0.1 0.64662 -0.08 0.64874 MirTarget; miRNATAP -0.18 0.00013 NA
86 hsa-let-7a-3p BNC2 0.1 0.64662 -0.53 0.08426 mirMAP -0.77 0 NA
87 hsa-miR-146b-5p BRAF -0.17 0.52079 0.04 0.67655 miRanda -0.12 0.00232 21874046; 26883911; 20406109; 21537871 Additionally the activation of thyroid most common oncogenes RET/PTC3 and BRAF in PCCL3 cells upregulated miR-146b-5p expression;miR-146b-5p positively regulates migration and invasion of thyroid normal and tumor follicular cells independently from their original mutation either BRAF or RET/PTC through a mechanism that involves the actin cytoskeleton but not an increased capacity of matrix degradation;The miR-146b expression levels in PTCs with BRAF mutation were significantly higher than those without this mutation p < 0.0001;Among BRAF-positive tumors overexpression of miR-146b was associated with aggressive behavior suggesting that it may further refine the prognostic importance of BRAF
88 hsa-miR-199a-5p BRAF -0.21 0.45417 0.04 0.67655 miRanda -0.1 0.00848 NA
89 hsa-miR-199b-5p BRAF -0.11 0.66212 0.04 0.67655 miRanda -0.12 0.0002 NA
90 hsa-let-7a-3p BST1 0.1 0.64662 -0.17 0.51458 MirTarget -0.38 0.00024 NA
91 hsa-let-7a-3p BTC 0.1 0.64662 0.16 0.34142 mirMAP -0.2 0.00283 NA
92 hsa-let-7a-3p BVES 0.1 0.64662 -0.68 0.00965 mirMAP -0.64 0 NA
93 hsa-miR-539-5p CAB39 0.26 0.1605 -0.06 0.69756 mirMAP -0.11 1.0E-5 NA
94 hsa-miR-155-5p CAB39L -0.03 0.90329 0.76 0.01343 miRNAWalker2 validate -0.57 0 NA
95 hsa-miR-342-3p CAB39L -0.04 0.86845 0.76 0.01343 miRanda -0.35 0.00145 NA
96 hsa-miR-582-5p CAB39L -0.23 0.23741 0.76 0.01343 miRNATAP -0.68 0 NA
97 hsa-miR-590-3p CAB39L 0.61 0.00852 0.76 0.01343 miRanda -0.33 0.00021 NA
98 hsa-miR-590-5p CAB39L 0.31 0.18767 0.76 0.01343 miRanda -0.22 0.01941 NA
99 hsa-miR-7-1-3p CAB39L -0.05 0.80443 0.76 0.01343 mirMAP -0.35 0.00083 NA
100 hsa-let-7a-3p CACNA1C 0.1 0.64662 -0.71 0.00976 MirTarget -0.23 0.03112 NA
101 hsa-let-7a-3p CACNA2D1 0.1 0.64662 -0.85 0.05575 mirMAP -1.24 0 NA
102 hsa-let-7a-3p CACNG4 0.1 0.64662 -0.13 0.84396 MirTarget -0.55 0.03405 NA
103 hsa-let-7a-3p CCDC102B 0.1 0.64662 -0.36 0.06947 MirTarget -0.29 0.00016 NA
104 hsa-let-7a-3p CCDC50 0.1 0.64662 0 0.99286 miRNATAP -0.14 0 NA
105 hsa-let-7a-3p CCPG1 0.1 0.64662 -0.39 0.02629 mirMAP -0.18 0.00016 NA
106 hsa-let-7a-3p CD109 0.1 0.64662 -1.09 0.00327 mirMAP -0.58 7.0E-5 NA
107 hsa-let-7a-3p CD302 0.1 0.64662 -0.12 0.45976 mirMAP -0.17 0.00116 NA
108 hsa-let-7a-3p CD38 0.1 0.64662 -0.17 0.67186 MirTarget -0.66 4.0E-5 NA
109 hsa-let-7a-3p CDC14A 0.1 0.64662 0.23 0.1056 mirMAP -0.15 0.00458 NA
110 hsa-let-7a-3p CDC42EP3 0.1 0.64662 -0.09 0.6131 MirTarget; mirMAP -0.25 3.0E-5 NA
111 hsa-let-7a-3p CDK17 0.1 0.64662 -0.17 0.19208 MirTarget; miRNATAP -0.12 0.00022 NA
112 hsa-let-7a-3p CDS2 0.1 0.64662 0.22 0.14006 mirMAP -0.12 0.00961 NA
113 hsa-let-7a-3p CFL2 0.1 0.64662 -0.32 0.0855 mirMAP -0.42 0 NA
114 hsa-let-7a-3p CHL1 0.1 0.64662 -0.75 0.06297 MirTarget; miRNATAP -0.94 0 NA
115 hsa-let-7a-3p CHM 0.1 0.64662 0.22 0.12556 MirTarget -0.13 0.00246 NA
116 hsa-let-7a-3p CHST2 0.1 0.64662 -0.43 0.03475 MirTarget -0.3 0.0002 NA
117 hsa-let-7a-3p CLIC4 0.1 0.64662 -0.29 0.16683 MirTarget -0.38 0 NA
118 hsa-let-7a-3p CLIP1 0.1 0.64662 -0.12 0.44177 miRNATAP -0.13 3.0E-5 NA
119 hsa-let-7a-3p CLOCK 0.1 0.64662 -0.23 0.13672 MirTarget -0.12 0.02498 NA
120 hsa-let-7a-3p CNR1 0.1 0.64662 -0.02 0.96823 mirMAP -0.91 0 NA
121 hsa-let-7a-3p CNTN1 0.1 0.64662 -0.82 0.0942 MirTarget; miRNATAP -1.19 0 NA
122 hsa-let-7a-3p COL11A1 0.1 0.64662 -1.04 0.02407 MirTarget; miRNATAP -0.97 0 NA
123 hsa-let-7a-3p COL12A1 0.1 0.64662 -0.57 0.0671 miRNATAP -0.53 0 NA
124 hsa-let-7a-3p COL15A1 0.1 0.64662 -0.63 0.0177 MirTarget -0.44 0 NA
125 hsa-let-7a-3p COL1A2 0.1 0.64662 -0.68 0.0675 MirTarget -0.58 0 NA
126 hsa-let-7a-3p COL4A1 0.1 0.64662 -0.46 0.06991 miRNATAP -0.37 0 NA
127 hsa-let-7a-3p COL9A1 0.1 0.64662 0.18 0.73265 mirMAP -0.49 0.0225 NA
128 hsa-let-7a-3p CORO1C 0.1 0.64662 0.01 0.94477 MirTarget; miRNATAP -0.12 0.00019 NA
129 hsa-let-7a-3p CPEB4 0.1 0.64662 -0.14 0.38436 mirMAP; miRNATAP -0.2 5.0E-5 NA
130 hsa-let-7a-3p CRISPLD1 0.1 0.64662 -0.88 0.00802 MirTarget; miRNATAP -0.82 0 NA
131 hsa-let-7a-3p CTSC 0.1 0.64662 0.1 0.62013 mirMAP -0.13 0.00792 NA
132 hsa-let-7a-3p CUL4B 0.1 0.64662 0.29 0.06522 mirMAP -0.1 0.00249 NA
133 hsa-let-7a-3p CX3CR1 0.1 0.64662 -0.11 0.7119 MirTarget -0.65 0 NA
134 hsa-let-7a-3p CXXC4 0.1 0.64662 0.28 0.40277 mirMAP -0.32 0.01577 NA
135 hsa-let-7a-3p CYBRD1 0.1 0.64662 -0.54 0.05877 mirMAP -0.53 0 NA
136 hsa-let-7a-3p CYP1B1 0.1 0.64662 -0.87 0.02956 mirMAP -0.94 0 NA
137 hsa-let-7a-3p DAAM1 0.1 0.64662 -0.28 0.04584 MirTarget -0.14 0.00396 NA
138 hsa-let-7a-3p DAB1 0.1 0.64662 0.7 0.07963 mirMAP -0.4 0.01098 NA
139 hsa-let-7a-3p DACT1 0.1 0.64662 -0.88 0.00156 MirTarget -0.45 2.0E-5 NA
140 hsa-let-7a-3p DCBLD2 0.1 0.64662 0 0.98904 miRNATAP -0.22 0.00961 NA
141 hsa-miR-101-3p DDIT4 0.06 0.84439 -0.22 0.40802 miRNAWalker2 validate; MirTarget; miRNATAP -0.33 0.00086 NA
142 hsa-miR-181d-5p DDIT4 0.77 0.00142 -0.22 0.40802 MirTarget -0.15 0.00566 NA
143 hsa-miR-217 DDIT4 0.21 0.45929 -0.22 0.40802 miRanda -0.2 6.0E-5 NA
144 hsa-miR-30d-5p DDIT4 0.02 0.95554 -0.22 0.40802 MirTarget; miRNATAP -0.22 0.01005 NA
145 hsa-miR-30e-5p DDIT4 0.16 0.58457 -0.22 0.40802 MirTarget -0.22 0.03055 NA
146 hsa-let-7a-3p DENND1B 0.1 0.64662 -0.09 0.57004 mirMAP -0.12 0.04572 NA
147 hsa-let-7a-3p DIO2 0.1 0.64662 -0.24 0.41375 mirMAP -0.77 0 NA
148 hsa-let-7a-3p DKK3 0.1 0.64662 -0.46 0.04838 MirTarget; miRNATAP -0.49 0 NA
149 hsa-let-7a-3p DNAJB5 0.1 0.64662 -0.44 0.0463 miRNATAP -0.53 0 NA
150 hsa-let-7a-3p DNALI1 0.1 0.64662 -0.59 0.11083 MirTarget; miRNATAP -0.35 0.01822 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 111 1672 4.812e-26 2.239e-22
2 NEUROGENESIS 96 1402 2.537e-23 5.902e-20
3 REGULATION OF CELL DIFFERENTIATION 96 1492 2.217e-21 3.439e-18
4 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 82 1142 3.918e-21 4.25e-18
5 REGULATION OF CELL DEVELOPMENT 69 836 4.567e-21 4.25e-18
6 CARDIOVASCULAR SYSTEM DEVELOPMENT 64 788 3.312e-19 2.202e-16
7 CIRCULATORY SYSTEM DEVELOPMENT 64 788 3.312e-19 2.202e-16
8 CELL DEVELOPMENT 89 1426 6.38e-19 3.711e-16
9 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 83 1275 9.746e-19 5.039e-16
10 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 87 1395 1.807e-18 8.409e-16
11 REGULATION OF CELLULAR COMPONENT MOVEMENT 62 771 2.081e-18 8.802e-16
12 LOCOMOTION 76 1114 2.642e-18 1.024e-15
13 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 72 1021 3.951e-18 1.414e-15
14 BLOOD VESSEL MORPHOGENESIS 40 364 1.071e-16 3.558e-14
15 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 58 750 1.744e-16 5.409e-14
16 REGULATION OF CELL DEATH 85 1472 4.931e-16 1.434e-13
17 POSITIVE REGULATION OF CELL DIFFERENTIATION 60 823 7.612e-16 2.083e-13
18 NEURON DIFFERENTIATION 62 874 8.56e-16 2.213e-13
19 CELLULAR COMPONENT MORPHOGENESIS 62 900 3.341e-15 8.183e-13
20 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 64 957 4.603e-15 1.02e-12
21 TUBE DEVELOPMENT 47 552 4.501e-15 1.02e-12
22 VASCULATURE DEVELOPMENT 43 469 5.316e-15 1.124e-12
23 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 45 513 6.059e-15 1.226e-12
24 NEGATIVE REGULATION OF CELL DEATH 60 872 1.037e-14 2.011e-12
25 RESPONSE TO ENDOGENOUS STIMULUS 81 1450 1.739e-14 3.237e-12
26 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 56 801 4.55e-14 8.142e-12
27 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 87 1656 5.242e-14 8.711e-12
28 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 64 1008 5.136e-14 8.711e-12
29 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 51 689 7.635e-14 1.225e-11
30 PROTEIN PHOSPHORYLATION 61 944 1.003e-13 1.555e-11
31 INTRACELLULAR SIGNAL TRANSDUCTION 83 1572 1.735e-13 2.604e-11
32 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 92 1848 1.993e-13 2.898e-11
33 POSITIVE REGULATION OF LOCOMOTION 38 420 3.338e-13 4.672e-11
34 ORGAN MORPHOGENESIS 56 841 3.414e-13 4.672e-11
35 POSITIVE REGULATION OF RESPONSE TO STIMULUS 94 1929 3.597e-13 4.782e-11
36 REGULATION OF EPITHELIAL CELL PROLIFERATION 31 285 4.421e-13 5.714e-11
37 CELL PROJECTION ORGANIZATION 58 902 5.35e-13 6.728e-11
38 TISSUE DEVELOPMENT 80 1518 5.744e-13 7.034e-11
39 POSITIVE REGULATION OF CELL DEVELOPMENT 40 472 6.442e-13 7.686e-11
40 CELL MOTILITY 55 835 8.762e-13 9.943e-11
41 LOCALIZATION OF CELL 55 835 8.762e-13 9.943e-11
42 ANGIOGENESIS 31 293 9.273e-13 1.027e-10
43 CENTRAL NERVOUS SYSTEM DEVELOPMENT 56 872 1.48e-12 1.602e-10
44 REGULATION OF NEURON DIFFERENTIATION 43 554 1.645e-12 1.701e-10
45 PHOSPHORYLATION 69 1228 1.612e-12 1.701e-10
46 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 62 1036 1.78e-12 1.762e-10
47 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 62 1036 1.78e-12 1.762e-10
48 POSITIVE REGULATION OF CELL COMMUNICATION 79 1532 2.508e-12 2.431e-10
49 NEURON PROJECTION DEVELOPMENT 42 545 3.828e-12 3.635e-10
50 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 37 437 5.061e-12 4.71e-10
51 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 32 337 7.355e-12 6.71e-10
52 HEART DEVELOPMENT 38 466 8.011e-12 7.033e-10
53 REGULATION OF CELL ADHESION 45 629 7.932e-12 7.033e-10
54 NEGATIVE REGULATION OF CELL DIFFERENTIATION 44 609 9.937e-12 8.563e-10
55 REGULATION OF PHOSPHORUS METABOLIC PROCESS 80 1618 1.484e-11 1.256e-09
56 REGULATION OF CELLULAR COMPONENT BIOGENESIS 50 767 1.526e-11 1.268e-09
57 REGULATION OF DEVELOPMENTAL GROWTH 29 289 1.899e-11 1.55e-09
58 TISSUE MORPHOGENESIS 40 533 2.901e-11 2.31e-09
59 TAXIS 37 464 2.929e-11 2.31e-09
60 HEAD DEVELOPMENT 47 709 3.701e-11 2.87e-09
61 RESPONSE TO OXYGEN CONTAINING COMPOUND 71 1381 4.512e-11 3.442e-09
62 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 57 983 5.337e-11 4.005e-09
63 MESENCHYME DEVELOPMENT 23 190 5.643e-11 4.163e-09
64 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 38 498 5.726e-11 4.163e-09
65 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 50 799 6.55e-11 4.689e-09
66 REGULATION OF CELL PROJECTION ORGANIZATION 40 558 1.162e-10 8.192e-09
67 NEURON DEVELOPMENT 45 687 1.469e-10 1.004e-08
68 MORPHOGENESIS OF AN EPITHELIUM 33 400 1.48e-10 1.004e-08
69 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 62 1152 1.488e-10 1.004e-08
70 REGULATION OF TRANSPORT 83 1804 2.134e-10 1.419e-08
71 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 73 1492 2.197e-10 1.44e-08
72 RESPONSE TO GROWTH FACTOR 36 475 2.261e-10 1.441e-08
73 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 61 1135 2.257e-10 1.441e-08
74 REGULATION OF NEURON PROJECTION DEVELOPMENT 33 408 2.479e-10 1.558e-08
75 REGULATION OF ORGAN MORPHOGENESIS 25 242 2.585e-10 1.604e-08
76 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 20 154 2.892e-10 1.77e-08
77 REGULATION OF CELL SUBSTRATE ADHESION 21 173 3.705e-10 2.239e-08
78 BEHAVIOR 37 516 5.94e-10 3.543e-08
79 SENSORY ORGAN DEVELOPMENT 36 493 6.26e-10 3.645e-08
80 REGULATION OF STEM CELL DIFFERENTIATION 17 113 6.268e-10 3.645e-08
81 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 8 16 6.785e-10 3.898e-08
82 POSITIVE REGULATION OF MOLECULAR FUNCTION 81 1791 8.346e-10 4.736e-08
83 SINGLE ORGANISM BEHAVIOR 31 384 9.23e-10 5.174e-08
84 SKELETAL SYSTEM DEVELOPMENT 34 455 1.054e-09 5.839e-08
85 REGULATION OF CELL MORPHOGENESIS 38 552 1.087e-09 5.949e-08
86 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 18 133 1.149e-09 6.145e-08
87 GROWTH 32 410 1.139e-09 6.145e-08
88 MORPHOGENESIS OF A BRANCHING STRUCTURE 20 167 1.241e-09 6.487e-08
89 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 16 103 1.237e-09 6.487e-08
90 TUBE MORPHOGENESIS 28 323 1.255e-09 6.488e-08
91 REGULATION OF GROWTH 41 633 1.412e-09 7.221e-08
92 REGULATION OF CELL MATRIX ADHESION 15 90 1.489e-09 7.53e-08
93 NEGATIVE REGULATION OF CELL COMMUNICATION 61 1192 1.526e-09 7.634e-08
94 POSITIVE REGULATION OF GENE EXPRESSION 78 1733 2.28e-09 1.129e-07
95 REGULATION OF NEURON APOPTOTIC PROCESS 21 192 2.54e-09 1.244e-07
96 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 13 67 2.681e-09 1.299e-07
97 INOSITOL LIPID MEDIATED SIGNALING 17 124 2.727e-09 1.308e-07
98 HEART MORPHOGENESIS 22 212 2.857e-09 1.357e-07
99 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 23 232 3.03e-09 1.412e-07
100 EMBRYO DEVELOPMENT 50 894 3.054e-09 1.412e-07
101 REGULATION OF NEURON DEATH 24 252 3.065e-09 1.412e-07
102 OUTFLOW TRACT MORPHOGENESIS 12 56 3.315e-09 1.512e-07
103 REGULATION OF CELL PROLIFERATION 70 1496 3.616e-09 1.634e-07
104 REGULATION OF OSSIFICATION 20 178 3.819e-09 1.709e-07
105 POSITIVE REGULATION OF KINASE ACTIVITY 34 482 4.603e-09 2.04e-07
106 ACTIVATION OF PROTEIN KINASE ACTIVITY 25 279 5.018e-09 2.203e-07
107 POSITIVE REGULATION OF OSSIFICATION 14 84 5.262e-09 2.288e-07
108 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 29 368 5.633e-09 2.427e-07
109 REGULATION OF PROTEIN MODIFICATION PROCESS 76 1710 6.609e-09 2.821e-07
110 EMBRYONIC MORPHOGENESIS 36 539 6.732e-09 2.848e-07
111 EPITHELIUM DEVELOPMENT 51 945 6.89e-09 2.868e-07
112 REGULATION OF EPITHELIAL CELL MIGRATION 19 166 6.902e-09 2.868e-07
113 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 84 1977 7.354e-09 3.028e-07
114 RESPONSE TO HORMONE 49 893 8.235e-09 3.348e-07
115 NEURON PROJECTION GUIDANCE 21 205 8.276e-09 3.348e-07
116 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 16 118 9.421e-09 3.779e-07
117 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 13 74 9.584e-09 3.811e-07
118 POSITIVE REGULATION OF CELL PROLIFERATION 46 814 1.002e-08 3.95e-07
119 NEURON PROJECTION MORPHOGENESIS 30 402 1.073e-08 4.196e-07
120 REGULATION OF ADHERENS JUNCTION ORGANIZATION 11 50 1.123e-08 4.346e-07
121 NEGATIVE REGULATION OF NEURON DEATH 19 171 1.13e-08 4.346e-07
122 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 22 229 1.196e-08 4.561e-07
123 CELLULAR RESPONSE TO HORMONE STIMULUS 36 552 1.249e-08 4.724e-07
124 REGULATION OF HYDROLASE ACTIVITY 63 1327 1.434e-08 5.379e-07
125 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 64 1360 1.513e-08 5.632e-07
126 POSITIVE REGULATION OF CATALYTIC ACTIVITY 69 1518 1.533e-08 5.662e-07
127 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 11 53 2.156e-08 7.899e-07
128 POSITIVE REGULATION OF NEURON DIFFERENTIATION 25 306 3.192e-08 1.161e-06
129 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 11 55 3.25e-08 1.172e-06
130 REGULATION OF CELL JUNCTION ASSEMBLY 12 68 3.387e-08 1.212e-06
131 REGULATION OF SYNAPSE ORGANIZATION 15 113 3.669e-08 1.303e-06
132 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 16 131 4.286e-08 1.511e-06
133 CELL PART MORPHOGENESIS 38 633 4.396e-08 1.532e-06
134 REGULATION OF MAPK CASCADE 39 660 4.411e-08 1.532e-06
135 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 51 1004 4.891e-08 1.686e-06
136 MUSCLE STRUCTURE DEVELOPMENT 30 432 5.404e-08 1.849e-06
137 REGULATION OF KINASE ACTIVITY 43 776 5.47e-08 1.858e-06
138 MESENCHYMAL CELL DIFFERENTIATION 16 134 5.919e-08 1.996e-06
139 STEM CELL DIFFERENTIATION 19 190 6.291e-08 2.106e-06
140 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 76 1805 6.47e-08 2.15e-06
141 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 16 135 6.578e-08 2.171e-06
142 AMEBOIDAL TYPE CELL MIGRATION 17 154 7.375e-08 2.417e-06
143 REGULATION OF VASCULATURE DEVELOPMENT 21 233 7.779e-08 2.531e-06
144 NEGATIVE REGULATION OF CELL DEVELOPMENT 24 303 1.08e-07 3.467e-06
145 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 24 303 1.08e-07 3.467e-06
146 EYE DEVELOPMENT 25 326 1.094e-07 3.487e-06
147 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 39 684 1.127e-07 3.567e-06
148 BIOLOGICAL ADHESION 51 1032 1.159e-07 3.645e-06
149 POSITIVE REGULATION OF CELL ADHESION 27 376 1.296e-07 4.046e-06
150 RESPONSE TO ORGANIC CYCLIC COMPOUND 47 917 1.318e-07 4.088e-06
151 CELLULAR RESPONSE TO NITROGEN COMPOUND 32 505 1.592e-07 4.907e-06
152 DEVELOPMENTAL GROWTH 25 333 1.643e-07 5.029e-06
153 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 47 926 1.753e-07 5.263e-06
154 REGULATION OF SYSTEM PROCESS 32 507 1.741e-07 5.263e-06
155 EMBRYONIC ORGAN DEVELOPMENT 28 406 1.747e-07 5.263e-06
156 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 74 1784 1.806e-07 5.386e-06
157 REGULATION OF ACTIN FILAMENT BASED PROCESS 24 312 1.861e-07 5.515e-06
158 REGULATION OF SYNAPSE ASSEMBLY 12 79 1.905e-07 5.609e-06
159 RESPONSE TO WOUNDING 34 563 2.016e-07 5.9e-06
160 NEGATIVE REGULATION OF GENE EXPRESSION 65 1493 2.08e-07 6.049e-06
161 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 23 296 2.806e-07 8.059e-06
162 REGULATION OF ENDOTHELIAL CELL MIGRATION 14 114 2.805e-07 8.059e-06
163 UROGENITAL SYSTEM DEVELOPMENT 23 299 3.355e-07 9.578e-06
164 RESPONSE TO LIPID 45 888 3.412e-07 9.68e-06
165 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 65 1517 3.675e-07 1.036e-05
166 REGULATION OF EXTENT OF CELL GROWTH 13 101 4.308e-07 1.208e-05
167 REGULATION OF CYTOSKELETON ORGANIZATION 31 502 4.374e-07 1.219e-05
168 POSITIVE REGULATION OF GROWTH 20 238 4.914e-07 1.361e-05
169 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 15 138 5.287e-07 1.456e-05
170 RESPIRATORY SYSTEM DEVELOPMENT 18 197 5.411e-07 1.472e-05
171 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 27 404 5.396e-07 1.472e-05
172 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 35 616 5.613e-07 1.519e-05
173 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 44 876 5.909e-07 1.589e-05
174 CELLULAR RESPONSE TO LIPID 29 457 5.964e-07 1.595e-05
175 RESPONSE TO EXTERNAL STIMULUS 73 1821 8.152e-07 2.167e-05
176 REGULATION OF GLUCOSE IMPORT 10 60 8.297e-07 2.169e-05
177 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 10 60 8.297e-07 2.169e-05
178 REGULATED EXOCYTOSIS 19 224 8.232e-07 2.169e-05
179 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 11 75 8.88e-07 2.295e-05
180 NEURAL CREST CELL DIFFERENTIATION 11 75 8.88e-07 2.295e-05
181 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 7 25 9.431e-07 2.424e-05
182 EPITHELIAL CELL DIFFERENTIATION 30 495 9.94e-07 2.541e-05
183 SYNAPSE ORGANIZATION 15 145 1.001e-06 2.545e-05
184 POSITIVE CHEMOTAXIS 8 36 1.074e-06 2.717e-05
185 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 18 207 1.117e-06 2.795e-05
186 POSITIVE REGULATION OF MAP KINASE ACTIVITY 18 207 1.117e-06 2.795e-05
187 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 9 49 1.262e-06 3.139e-05
188 REGULATION OF AXONOGENESIS 16 168 1.333e-06 3.299e-05
189 WNT SIGNALING PATHWAY 24 351 1.554e-06 3.825e-05
190 REGULATION OF LIPID METABOLIC PROCESS 21 282 1.835e-06 4.494e-05
191 REGULATION OF TRANSFERASE ACTIVITY 45 946 1.905e-06 4.641e-05
192 MUSCLE CELL DIFFERENTIATION 19 237 1.922e-06 4.658e-05
193 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 8 39 2.059e-06 4.963e-05
194 RESPONSE TO NITROGEN COMPOUND 42 859 2.15e-06 5.131e-05
195 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 38 740 2.144e-06 5.131e-05
196 LIPID PHOSPHORYLATION 12 99 2.291e-06 5.439e-05
197 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 13 117 2.359e-06 5.572e-05
198 REGULATION OF RESPONSE TO STRESS 61 1468 2.404e-06 5.65e-05
199 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 28 465 2.598e-06 6.074e-05
200 REGULATION OF CELLULAR COMPONENT SIZE 23 337 2.647e-06 6.158e-05
201 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 21 289 2.708e-06 6.269e-05
202 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 10 68 2.725e-06 6.278e-05
203 REGULATION OF CELL GROWTH 25 391 3.147e-06 7.214e-05
204 POSITIVE REGULATION OF MAPK CASCADE 28 470 3.188e-06 7.272e-05
205 POSITIVE REGULATION OF GLUCOSE TRANSPORT 8 42 3.723e-06 8.45e-05
206 CARDIAC CHAMBER MORPHOGENESIS 12 104 3.871e-06 8.745e-05
207 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 15 162 4.043e-06 9.088e-05
208 CELL FATE COMMITMENT 18 227 4.171e-06 9.33e-05
209 ACTIN FILAMENT BASED PROCESS 27 450 4.195e-06 9.339e-05
210 SECRETION 32 588 4.288e-06 9.5e-05
211 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 11 88 4.464e-06 9.843e-05
212 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 9 57 4.712e-06 0.0001034
213 REGULATION OF ION TRANSPORT 32 592 4.931e-06 0.0001077
214 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 18 232 5.656e-06 0.000123
215 LIPID MODIFICATION 17 210 5.84e-06 0.0001264
216 EXTRACELLULAR STRUCTURE ORGANIZATION 21 304 5.969e-06 0.0001286
217 SECRETION BY CELL 28 486 6.006e-06 0.0001288
218 CARTILAGE DEVELOPMENT 14 147 6.091e-06 0.0001294
219 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 25 406 6.09e-06 0.0001294
220 SPROUTING ANGIOGENESIS 8 45 6.409e-06 0.0001355
221 DIGESTIVE SYSTEM DEVELOPMENT 14 148 6.592e-06 0.0001382
222 POSITIVE REGULATION OF CELL GROWTH 14 148 6.592e-06 0.0001382
223 MUSCLE SYSTEM PROCESS 20 282 6.72e-06 0.0001402
224 APPENDAGE DEVELOPMENT 15 169 6.799e-06 0.0001406
225 LIMB DEVELOPMENT 15 169 6.799e-06 0.0001406
226 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 6 22 6.895e-06 0.000142
227 REGULATION OF BINDING 20 283 7.084e-06 0.0001452
228 REGULATION OF CELLULAR RESPONSE TO STRESS 35 691 7.374e-06 0.0001505
229 EXOCYTOSIS 21 310 8.062e-06 0.0001638
230 REGULATION OF RESPONSE TO WOUNDING 25 413 8.184e-06 0.0001656
231 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 19 262 8.298e-06 0.0001672
232 MEMBRANE DEPOLARIZATION 9 61 8.388e-06 0.0001675
233 REGULATION OF CELL SIZE 15 172 8.422e-06 0.0001675
234 REGULATION OF OSTEOBLAST DIFFERENTIATION 12 112 8.413e-06 0.0001675
235 SENSORY ORGAN MORPHOGENESIS 18 239 8.534e-06 0.000169
236 CONNECTIVE TISSUE DEVELOPMENT 16 194 8.654e-06 0.0001699
237 RESPONSE TO ALCOHOL 23 362 8.639e-06 0.0001699
238 NEGATIVE REGULATION OF LOCOMOTION 19 263 8.762e-06 0.0001708
239 PROTEIN LOCALIZATION 69 1805 8.772e-06 0.0001708
240 HEART VALVE DEVELOPMENT 7 34 8.859e-06 0.0001718
241 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 27 470 9.282e-06 0.0001792
242 CARDIAC VENTRICLE MORPHOGENESIS 9 62 9.62e-06 0.000185
243 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 14 153 9.683e-06 0.0001854
244 REGULATION OF ANATOMICAL STRUCTURE SIZE 27 472 1.002e-05 0.0001911
245 CELLULAR RESPONSE TO ACID CHEMICAL 15 175 1.038e-05 0.0001972
246 CARDIOCYTE DIFFERENTIATION 11 96 1.047e-05 0.000198
247 REGULATION OF GTPASE ACTIVITY 34 673 1.054e-05 0.0001986
248 REGULATION OF MEMBRANE POTENTIAL 22 343 1.168e-05 0.0002191
249 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 14 156 1.21e-05 0.0002261
250 RESPONSE TO ACID CHEMICAL 21 319 1.246e-05 0.0002309
251 REGULATION OF MAP KINASE ACTIVITY 21 319 1.246e-05 0.0002309
252 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 11 98 1.277e-05 0.0002359
253 RHYTHMIC PROCESS 20 298 1.513e-05 0.0002783
254 CELL ACTIVATION 30 568 1.525e-05 0.0002794
255 REGULATION OF GLUCOSE TRANSPORT 11 100 1.551e-05 0.0002819
256 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 6 25 1.545e-05 0.0002819
257 MUSCLE TISSUE DEVELOPMENT 19 275 1.646e-05 0.000298
258 COGNITION 18 251 1.663e-05 0.0002999
259 NEURAL CREST CELL MIGRATION 8 51 1.682e-05 0.0003022
260 POSITIVE REGULATION OF TRANSPORT 42 936 1.749e-05 0.0003131
261 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 9 67 1.836e-05 0.0003273
262 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 12 121 1.858e-05 0.00033
263 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 10 84 1.879e-05 0.0003324
264 COLLAGEN FIBRIL ORGANIZATION 7 38 1.923e-05 0.0003389
265 REGULATION OF MESONEPHROS DEVELOPMENT 6 26 1.971e-05 0.0003461
266 POSITIVE REGULATION OF CELL DEATH 31 605 1.982e-05 0.0003467
267 EMBRYONIC ORGAN MORPHOGENESIS 19 279 2.013e-05 0.0003508
268 PALATE DEVELOPMENT 10 85 2.087e-05 0.0003623
269 SYSTEM PROCESS 67 1785 2.166e-05 0.0003747
270 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 8 53 2.252e-05 0.000387
271 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 11 104 2.254e-05 0.000387
272 MUSCLE CONTRACTION 17 233 2.28e-05 0.00039
273 NEGATIVE CHEMOTAXIS 7 39 2.299e-05 0.0003918
274 CARDIAC CHAMBER DEVELOPMENT 13 144 2.316e-05 0.0003933
275 POSITIVE REGULATION OF AXONOGENESIS 9 69 2.339e-05 0.0003957
276 IMMUNE SYSTEM DEVELOPMENT 30 582 2.414e-05 0.000407
277 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 29 554 2.493e-05 0.0004155
278 RESPONSE TO STEROID HORMONE 27 497 2.5e-05 0.0004155
279 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 27 2.486e-05 0.0004155
280 NEGATIVE REGULATION OF MOLECULAR FUNCTION 46 1079 2.484e-05 0.0004155
281 CELL PROLIFERATION 33 672 2.518e-05 0.000417
282 KIDNEY EPITHELIUM DEVELOPMENT 12 125 2.58e-05 0.0004256
283 WOUND HEALING 26 470 2.598e-05 0.0004272
284 CARDIAC VENTRICLE DEVELOPMENT 11 106 2.698e-05 0.0004421
285 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 7 40 2.733e-05 0.0004461
286 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 16 213 2.771e-05 0.0004509
287 REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 5 17 2.791e-05 0.0004524
288 CELL CELL SIGNALING 36 767 2.814e-05 0.0004547
289 OVULATION CYCLE PROCESS 10 88 2.835e-05 0.0004549
290 REGULATION OF STEM CELL PROLIFERATION 10 88 2.835e-05 0.0004549
291 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 15 191 2.933e-05 0.000469
292 PLATELET DEGRANULATION 11 107 2.948e-05 0.0004697
293 POSITIVE REGULATION OF BINDING 12 127 3.024e-05 0.0004802
294 REGULATION OF NEUROBLAST PROLIFERATION 6 28 3.105e-05 0.0004914
295 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 15 193 3.312e-05 0.0005223
296 CYTOSKELETON ORGANIZATION 38 838 3.558e-05 0.0005593
297 EAR DEVELOPMENT 15 195 3.733e-05 0.0005848
298 REGULATION OF COLLATERAL SPROUTING 5 18 3.793e-05 0.000592
299 EPITHELIAL CELL MORPHOGENESIS 7 42 3.804e-05 0.000592
300 NEURON MIGRATION 11 110 3.819e-05 0.0005923
301 CELL DEATH 43 1001 3.881e-05 0.0005979
302 STRIATED MUSCLE CELL DIFFERENTIATION 14 173 3.87e-05 0.0005979
303 REGULATION OF TRANSMEMBRANE TRANSPORT 24 426 3.968e-05 0.0006094
304 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 11 111 4.154e-05 0.0006359
305 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 28 541 4.197e-05 0.0006382
306 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 28 541 4.197e-05 0.0006382
307 REGULATION OF CELL ACTIVATION 26 484 4.258e-05 0.0006454
308 REGULATION OF BLOOD CIRCULATION 19 295 4.326e-05 0.0006535
309 POSITIVE REGULATION OF CELL DIVISION 12 132 4.437e-05 0.0006681
310 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 7 43 4.456e-05 0.0006689
311 POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 6 30 4.71e-05 0.0007025
312 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 6 30 4.71e-05 0.0007025
313 SINGLE ORGANISM CELL ADHESION 25 459 4.774e-05 0.0007075
314 RESPONSE TO DRUG 24 431 4.772e-05 0.0007075
315 REGULATION OF CELL DIVISION 18 272 4.82e-05 0.000712
316 OVULATION CYCLE 11 113 4.903e-05 0.0007219
317 ACTION POTENTIAL 10 94 5.038e-05 0.0007394
318 SKELETAL SYSTEM MORPHOGENESIS 15 201 5.292e-05 0.0007732
319 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 18 274 5.301e-05 0.0007732
320 STEM CELL PROLIFERATION 8 60 5.665e-05 0.0008224
321 MODULATION OF SYNAPTIC TRANSMISSION 19 301 5.674e-05 0.0008224
322 REGULATION OF CHEMOTAXIS 14 180 5.976e-05 0.0008635
323 MUSCLE ORGAN DEVELOPMENT 18 277 6.102e-05 0.000879
324 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 8 61 6.394e-05 0.0009154
325 POSITIVE REGULATION OF STEM CELL PROLIFERATION 8 61 6.394e-05 0.0009154
326 RESPONSE TO ABIOTIC STIMULUS 43 1024 6.533e-05 0.0009325
327 NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 5 20 6.613e-05 0.0009409
328 ENDOCARDIAL CUSHION DEVELOPMENT 6 32 6.92e-05 0.0009787
329 PATTERNING OF BLOOD VESSELS 6 32 6.92e-05 0.0009787
330 DENDRITE DEVELOPMENT 9 79 6.966e-05 0.0009823
331 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 10 98 7.205e-05 0.001013
332 MESODERM DEVELOPMENT 11 118 7.298e-05 0.001023
333 CARDIAC MUSCLE TISSUE DEVELOPMENT 12 140 7.884e-05 0.001102
334 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 13 162 7.924e-05 0.001104
335 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 7 47 8.049e-05 0.001118
336 REGULATION OF MUSCLE ADAPTATION 8 63 8.085e-05 0.00112
337 POSITIVE REGULATION OF HYDROLASE ACTIVITY 39 905 8.404e-05 0.00116
338 METANEPHROS DEVELOPMENT 9 81 8.488e-05 0.001162
339 EPITHELIAL CELL DEVELOPMENT 14 186 8.516e-05 0.001162
340 POSITIVE REGULATION OF NEUROBLAST PROLIFERATION 5 21 8.519e-05 0.001162
341 SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 5 21 8.519e-05 0.001162
342 LEUKOCYTE MIGRATION 17 259 8.593e-05 0.001169
343 POSITIVE REGULATION OF CELL ACTIVATION 19 311 8.76e-05 0.001188
344 VESICLE MEDIATED TRANSPORT 49 1239 8.892e-05 0.001203
345 REGULATION OF PHOSPHOLIPASE ACTIVITY 8 64 9.061e-05 0.001222
346 REGULATION OF LIPID KINASE ACTIVITY 7 48 9.243e-05 0.001243
347 NEGATIVE REGULATION OF GROWTH 16 236 9.461e-05 0.001265
348 NEGATIVE REGULATION OF PHOSPHORYLATION 23 422 9.436e-05 0.001265
349 REGULATION OF ORGANELLE ORGANIZATION 47 1178 0.0001014 0.001349
350 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 10 102 0.0001012 0.001349
351 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 12 144 0.0001034 0.001367
352 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 12 144 0.0001034 0.001367
353 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 22 397 0.0001051 0.001385
354 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 33 724 0.0001062 0.001394
355 MULTICELLULAR ORGANISMAL SIGNALING 11 123 0.0001063 0.001394
356 SOMATIC STEM CELL DIVISION 5 22 0.0001082 0.001414
357 POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 4 12 0.0001085 0.001414
358 LEUKOCYTE DIFFERENTIATION 18 292 0.0001194 0.001547
359 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 15 216 0.0001192 0.001547
360 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 7 50 0.0001206 0.001559
361 HEART PROCESS 9 85 0.0001238 0.001591
362 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 44 1087 0.0001236 0.001591
363 CELLULAR RESPONSE TO DRUG 8 67 0.0001259 0.001614
364 CELL CELL ADHESION 29 608 0.0001292 0.001652
365 PEPTIDYL SERINE MODIFICATION 12 148 0.0001343 0.001712
366 HEAD MORPHOGENESIS 6 36 0.0001379 0.001753
367 NEGATIVE REGULATION OF CELL PROLIFERATION 30 643 0.0001459 0.00185
368 MUSCLE CELL DEVELOPMENT 11 128 0.0001519 0.00192
369 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 20 352 0.0001541 0.001943
370 REPRODUCTIVE SYSTEM DEVELOPMENT 22 408 0.0001553 0.001953
371 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 23 437 0.0001579 0.001981
372 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 9 88 0.0001619 0.002019
373 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 6 37 0.0001614 0.002019
374 TUBE FORMATION 11 129 0.0001627 0.002025
375 NEURAL PRECURSOR CELL PROLIFERATION 8 70 0.0001718 0.002132
376 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 9 89 0.0001765 0.002185
377 CHEMICAL HOMEOSTASIS 37 874 0.0001822 0.002248
378 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 6 38 0.0001881 0.002315
379 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 10 110 0.00019 0.002332
380 LEUKOCYTE ACTIVATION 22 414 0.0001908 0.002337
381 CELL CYCLE ARREST 12 154 0.0001953 0.002385
382 CELLULAR EXTRAVASATION 5 25 0.0002065 0.002509
383 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 5 25 0.0002065 0.002509
384 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 4 14 0.0002116 0.002558
385 POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 4 14 0.0002116 0.002558
386 REGULATION OF AXON GUIDANCE 6 39 0.0002181 0.002625
387 PATTERN SPECIFICATION PROCESS 22 418 0.0002183 0.002625
388 BONE DEVELOPMENT 12 156 0.0002202 0.002641
389 REGULATION OF KIDNEY DEVELOPMENT 7 55 0.0002225 0.002662
390 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 11 134 0.0002275 0.002714
391 REGULATION OF ORGAN GROWTH 8 73 0.0002307 0.002739
392 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 8 73 0.0002307 0.002739
393 NEPHRON EPITHELIUM DEVELOPMENT 9 93 0.0002469 0.002923
394 EPITHELIAL TO MESENCHYMAL TRANSITION 7 56 0.0002494 0.002946
395 REGULATION OF MACROPHAGE ACTIVATION 5 26 0.000251 0.002949
396 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 5 26 0.000251 0.002949
397 RESPONSE TO KETONE 13 182 0.0002539 0.002968
398 ACTIN MEDIATED CELL CONTRACTION 8 74 0.0002537 0.002968
399 POSITIVE REGULATION OF ENDOCYTOSIS 10 114 0.0002546 0.002969
400 CIRCULATORY SYSTEM PROCESS 20 366 0.0002575 0.002996
401 EYE MORPHOGENESIS 11 136 0.0002589 0.003004
402 REGIONALIZATION 18 311 0.00026 0.00301
403 CELLULAR RESPONSE TO ALCOHOL 10 115 0.0002733 0.003148
404 NEPHRON DEVELOPMENT 10 115 0.0002733 0.003148
405 HINDBRAIN DEVELOPMENT 11 137 0.0002759 0.003162
406 ACTIVATION OF MAPK ACTIVITY 11 137 0.0002759 0.003162
407 POSITIVE REGULATION OF AUTOPHAGY 8 75 0.0002785 0.003184
408 MESENCHYMAL TO EPITHELIAL TRANSITION 4 15 0.0002835 0.003217
409 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 4 15 0.0002835 0.003217
410 CELLULAR RESPONSE TO STEROL 4 15 0.0002835 0.003217
411 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 6 41 0.0002894 0.003277
412 CELLULAR MACROMOLECULE LOCALIZATION 47 1234 0.0002941 0.003321
413 SINGLE ORGANISM CELLULAR LOCALIZATION 37 898 0.000308 0.003471
414 NEGATIVE REGULATION OF TRANSPORT 23 458 0.0003098 0.003482
415 CELL CHEMOTAXIS 12 162 0.0003121 0.003491
416 POSITIVE REGULATION OF RESPONSE TO WOUNDING 12 162 0.0003121 0.003491
417 MYELOID LEUKOCYTE DIFFERENTIATION 9 96 0.0003137 0.0035
418 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 8 77 0.0003341 0.003719
419 VASCULOGENESIS 7 59 0.0003463 0.003846
420 NEGATIVE REGULATION OF CELL CYCLE 22 433 0.0003551 0.003934
421 REGULATION OF FIBROBLAST MIGRATION 5 28 0.0003614 0.003994
422 RENAL TUBULE DEVELOPMENT 8 78 0.000365 0.004025
423 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 28 616 0.0003676 0.004043
424 NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT 4 16 0.0003713 0.004065
425 TOR SIGNALING 4 16 0.0003713 0.004065
426 PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 10 120 0.0003854 0.004189
427 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 7 60 0.0003846 0.004189
428 POSITIVE REGULATION OF CHEMOTAXIS 10 120 0.0003854 0.004189
429 STRIATED MUSCLE CONTRACTION 9 99 0.0003947 0.004251
430 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 9 99 0.0003947 0.004251
431 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 9 99 0.0003947 0.004251
432 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 9 99 0.0003947 0.004251
433 BODY MORPHOGENESIS 6 44 0.0004293 0.004571
434 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 7 61 0.0004261 0.004571
435 STEM CELL DIVISION 5 29 0.0004287 0.004571
436 CARDIAC MUSCLE CELL CONTRACTION 5 29 0.0004287 0.004571
437 NEUROBLAST PROLIFERATION 5 29 0.0004287 0.004571
438 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 10 122 0.0004398 0.004672
439 REGULATION OF CELL CYCLE 38 949 0.0004444 0.00471
440 CAMERA TYPE EYE MORPHOGENESIS 9 101 0.0004578 0.00483
441 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 9 101 0.0004578 0.00483
442 CELLULAR RESPONSE TO INSULIN STIMULUS 11 146 0.0004764 0.004953
443 REGULATION OF ENERGY HOMEOSTASIS 4 17 0.0004769 0.004953
444 REGULATION OF PROTEIN KINASE A SIGNALING 4 17 0.0004769 0.004953
445 POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS 4 17 0.0004769 0.004953
446 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 8 81 0.0004723 0.004953
447 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 4 17 0.0004769 0.004953
448 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 7 62 0.0004712 0.004953
449 NEGATIVE REGULATION OF CELL GROWTH 12 170 0.0004835 0.005011
450 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 5 30 0.000505 0.00521
451 NEGATIVE REGULATION OF CELL MATRIX ADHESION 5 30 0.000505 0.00521
452 REGULATION OF HEART CONTRACTION 14 221 0.0005075 0.005224
453 CELLULAR RESPONSE TO PEPTIDE 16 274 0.0005112 0.005251
454 REGULATION OF CARTILAGE DEVELOPMENT 7 63 0.00052 0.005318
455 RESPONSE TO OSMOTIC STRESS 7 63 0.00052 0.005318
456 REGULATION OF MUSCLE TISSUE DEVELOPMENT 9 103 0.0005289 0.005385
457 REGULATION OF MUSCLE ORGAN DEVELOPMENT 9 103 0.0005289 0.005385
458 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 13 197 0.0005434 0.00552
459 REGULATION OF HOMEOSTATIC PROCESS 22 447 0.0005454 0.005529
460 REGULATION OF AUTOPHAGY 15 249 0.0005496 0.00556
461 NEGATIVE REGULATION OF CELL ADHESION 14 223 0.000555 0.005602
462 REGULATION OF LIPASE ACTIVITY 8 83 0.000557 0.00561
463 NEURAL TUBE DEVELOPMENT 11 149 0.0005656 0.005684
464 OSTEOBLAST DIFFERENTIATION 10 126 0.0005678 0.005694
465 REGULATION OF TRANSPORTER ACTIVITY 13 198 0.0005699 0.005703
466 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 27 602 0.0005714 0.005706
467 REGULATION OF NEUROTRANSMITTER TRANSPORT 7 64 0.0005727 0.005706
468 REGULATION OF SYNAPTIC VESICLE TRANSPORT 5 31 0.0005911 0.005877
469 RETINAL GANGLION CELL AXON GUIDANCE 4 18 0.0006023 0.005944
470 TISSUE MIGRATION 8 84 0.0006038 0.005944
471 PHARYNGEAL SYSTEM DEVELOPMENT 4 18 0.0006023 0.005944
472 MAST CELL MEDIATED IMMUNITY 4 18 0.0006023 0.005944
473 NEGATIVE REGULATION OF ION TRANSPORT 10 127 0.0006042 0.005944
474 REGULATION OF APOPTOTIC SIGNALING PATHWAY 19 363 0.0006171 0.006058
475 REGULATION OF CELLULAR LOCALIZATION 47 1277 0.0006212 0.006085
476 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 13 200 0.0006264 0.006123
477 CELLULAR RESPONSE TO RETINOIC ACID 7 65 0.0006296 0.006129
478 NEGATIVE REGULATION OF AXONOGENESIS 7 65 0.0006296 0.006129
479 PROTEIN LOCALIZATION TO CELL PERIPHERY 11 151 0.0006326 0.006145
480 REGULATION OF FAT CELL DIFFERENTIATION 9 106 0.0006524 0.006323
481 CARDIAC SEPTUM DEVELOPMENT 8 85 0.0006537 0.006323
482 GLAND DEVELOPMENT 20 395 0.0006786 0.006551
483 DIGESTIVE TRACT MORPHOGENESIS 6 48 0.0006919 0.00661
484 MYOFIBRIL ASSEMBLY 6 48 0.0006919 0.00661
485 BLOOD VESSEL REMODELING 5 32 0.0006877 0.00661
486 TELENCEPHALON DEVELOPMENT 14 228 0.0006906 0.00661
487 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 6 48 0.0006919 0.00661
488 RESPONSE TO RETINOIC ACID 9 107 0.0006984 0.006659
489 LEUKOCYTE CELL CELL ADHESION 15 255 0.0007027 0.006686
490 IN UTERO EMBRYONIC DEVELOPMENT 17 311 0.0007295 0.006913
491 RESPONSE TO OXYGEN LEVELS 17 311 0.0007295 0.006913
492 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 4 19 0.0007495 0.007074
493 REGULATION OF ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLE PROPIONATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY 4 19 0.0007495 0.007074
494 REGULATION OF NUCLEOSIDE METABOLIC PROCESS 6 49 0.0007736 0.007243
495 REGULATION OF ATP METABOLIC PROCESS 6 49 0.0007736 0.007243
496 CARDIAC SEPTUM MORPHOGENESIS 6 49 0.0007736 0.007243
497 RETINA DEVELOPMENT IN CAMERA TYPE EYE 10 131 0.0007698 0.007243
498 NEGATIVE REGULATION OF ANION TRANSPORT 5 33 0.0007957 0.007435
499 LYMPHOCYTE ACTIVATION 18 342 0.0007987 0.007448
500 B CELL ACTIVATION 10 132 0.0008166 0.007599
501 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 6 50 0.0008627 0.007917
502 FORMATION OF PRIMARY GERM LAYER 9 110 0.0008527 0.007917
503 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 6 50 0.0008627 0.007917
504 REGULATION OF COENZYME METABOLIC PROCESS 6 50 0.0008627 0.007917
505 FACE DEVELOPMENT 6 50 0.0008627 0.007917
506 REGULATION OF COFACTOR METABOLIC PROCESS 6 50 0.0008627 0.007917
507 RHO PROTEIN SIGNAL TRANSDUCTION 6 50 0.0008627 0.007917
508 REGULATION OF PROTEIN LOCALIZATION 37 950 0.0008764 0.008027
509 EPITHELIAL CELL PROLIFERATION 8 89 0.0008874 0.008096
510 POST EMBRYONIC DEVELOPMENT 8 89 0.0008874 0.008096
511 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 5 34 0.0009159 0.008323
512 CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 5 34 0.0009159 0.008323
513 EMBRYONIC HEMOPOIESIS 4 20 0.0009203 0.008331
514 REGULATION OF NEURON PROJECTION REGENERATION 4 20 0.0009203 0.008331
515 LYMPHOCYTE DIFFERENTIATION 13 209 0.0009424 0.008514
516 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 6 51 0.0009594 0.008651
517 ADULT BEHAVIOR 10 135 0.0009711 0.008706
518 EAR MORPHOGENESIS 9 112 0.0009701 0.008706
519 CELL GROWTH 10 135 0.0009711 0.008706
520 RESPONSE TO ETHANOL 10 136 0.001028 0.009166
521 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 13 211 0.001028 0.009166
522 SKIN DEVELOPMENT 13 211 0.001028 0.009166
523 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING 7 71 0.001072 0.009535
524 SEX DIFFERENTIATION 15 266 0.001078 0.009574
525 INNER EAR MORPHOGENESIS 8 92 0.001103 0.009778
526 CHONDROCYTE DEVELOPMENT 4 21 0.001117 0.00986
527 MAST CELL ACTIVATION 4 21 0.001117 0.00986
NumGOOverlapSizeP ValueAdj. P Value
1 KINASE ACTIVITY 51 842 1.328e-10 1.234e-07
2 PROTEIN KINASE ACTIVITY 42 640 5.926e-10 2.752e-07
3 CYTOKINE BINDING 15 92 2.044e-09 6.33e-07
4 ENZYME BINDING 77 1737 5.769e-09 8.932e-07
5 RECEPTOR BINDING 69 1476 4.951e-09 8.932e-07
6 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 53 992 4.782e-09 8.932e-07
7 MOLECULAR FUNCTION REGULATOR 64 1353 1.244e-08 1.651e-06
8 GROWTH FACTOR ACTIVITY 18 160 2.264e-08 2.629e-06
9 PROTEIN SERINE THREONINE KINASE ACTIVITY 31 445 3.001e-08 3.098e-06
10 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 12 70 4.751e-08 4.414e-06
11 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 25 328 1.231e-07 9.526e-06
12 GROWTH FACTOR BINDING 15 123 1.158e-07 9.526e-06
13 MACROMOLECULAR COMPLEX BINDING 60 1399 1.065e-06 7.612e-05
14 CHEMOATTRACTANT ACTIVITY 7 27 1.676e-06 0.0001112
15 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 11 81 1.947e-06 0.0001206
16 HEPARIN BINDING 15 157 2.737e-06 0.0001589
17 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 18 226 3.92e-06 0.0002142
18 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 8 43 4.484e-06 0.0002314
19 GROWTH FACTOR RECEPTOR BINDING 13 129 7.029e-06 0.0003437
20 KINASE BINDING 32 606 7.951e-06 0.0003693
21 ENZYME REGULATOR ACTIVITY 43 959 1.408e-05 0.0006231
22 SIGNAL TRANSDUCER ACTIVITY 66 1731 1.538e-05 0.0006496
23 GLYCOSAMINOGLYCAN BINDING 16 205 1.729e-05 0.0006692
24 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 8 51 1.682e-05 0.0006692
25 TRANSFORMING GROWTH FACTOR BETA BINDING 5 16 2.007e-05 0.0007458
26 SULFUR COMPOUND BINDING 17 234 2.409e-05 0.0008606
27 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 31 629 4.149e-05 0.001427
28 VOLTAGE GATED SODIUM CHANNEL ACTIVITY 5 20 6.613e-05 0.002194
29 PROTEIN COMPLEX BINDING 40 935 7.962e-05 0.002551
30 KINASE REGULATOR ACTIVITY 14 186 8.516e-05 0.002637
31 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 8 64 9.061e-05 0.002715
32 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 19 315 0.0001036 0.003008
33 INTEGRIN BINDING 10 105 0.0001291 0.003634
34 CAMP BINDING 5 23 0.0001357 0.003659
35 CYCLIC NUCLEOTIDE BINDING 6 36 0.0001379 0.003659
36 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 47 1199 0.0001531 0.003951
37 ADENYL NUCLEOTIDE BINDING 56 1514 0.0001618 0.003955
38 SODIUM CHANNEL ACTIVITY 6 37 0.0001614 0.003955
39 REGULATORY REGION NUCLEIC ACID BINDING 35 818 0.0002229 0.005311
40 RIBONUCLEOTIDE BINDING 65 1860 0.0002352 0.005462
41 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 8 76 0.0003053 0.006917
42 PROTEIN KINASE A BINDING 6 42 0.0003313 0.007328
43 FIBRONECTIN BINDING 5 28 0.0003614 0.007808
44 RECEPTOR AGONIST ACTIVITY 4 16 0.0003713 0.007839
45 VOLTAGE GATED ION CHANNEL ACTIVITY 13 190 0.0003851 0.00795
46 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 9 101 0.0004578 0.009245
NumGOOverlapSizeP ValueAdj. P Value
1 CELL PROJECTION 86 1786 8.754e-12 5.113e-09
2 NEURON PROJECTION 56 942 3.094e-11 9.034e-09
3 NEURON PART 67 1265 4.847e-11 9.436e-09
4 SYNAPSE 45 754 2.792e-09 4.029e-07
5 CYTOPLASMIC VESICLE PART 39 601 3.449e-09 4.029e-07
6 INTRACELLULAR VESICLE 60 1259 2.894e-08 2.817e-06
7 POSTSYNAPSE 28 378 3.925e-08 3.275e-06
8 SYNAPSE PART 37 610 5.124e-08 3.741e-06
9 PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX 7 20 1.677e-07 1.088e-05
10 CELL PROJECTION PART 47 946 3.251e-07 1.899e-05
11 EXTRACELLULAR MATRIX 28 426 4.643e-07 2.465e-05
12 EXCITATORY SYNAPSE 18 197 5.411e-07 2.633e-05
13 SOMATODENDRITIC COMPARTMENT 36 650 7.055e-07 3.169e-05
14 PROTEINACEOUS EXTRACELLULAR MATRIX 24 356 1.99e-06 8.302e-05
15 CELL JUNCTION 51 1151 2.98e-06 0.000116
16 EXTRACELLULAR SPACE 57 1376 5.869e-06 0.0002142
17 PLATELET ALPHA GRANULE 10 75 6.753e-06 0.000232
18 VOLTAGE GATED SODIUM CHANNEL COMPLEX 5 14 9.547e-06 0.0003098
19 VESICLE MEMBRANE 28 512 1.571e-05 0.0004828
20 SECRETORY GRANULE LUMEN 10 85 2.087e-05 0.0006094
21 AXON 24 418 2.932e-05 0.0007551
22 SODIUM CHANNEL COMPLEX 5 17 2.791e-05 0.0007551
23 PLATELET ALPHA GRANULE LUMEN 8 55 2.974e-05 0.0007551
24 SECRETORY VESICLE 25 461 5.122e-05 0.001196
25 CELL SURFACE 35 757 4.938e-05 0.001196
26 RECEPTOR COMPLEX 20 327 5.658e-05 0.001271
27 MEMBRANE REGION 46 1134 8.21e-05 0.001776
28 TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 16 237 9.941e-05 0.002073
29 EXTRACELLULAR MATRIX COMPONENT 11 125 0.0001229 0.002475
30 VESICLE LUMEN 10 106 0.0001397 0.00272
31 CELL BODY 25 494 0.0001525 0.002873
32 ACTIN BASED CELL PROJECTION 13 181 0.0002406 0.00439
33 PRESYNAPSE 17 283 0.0002485 0.004398
34 FILOPODIUM 9 94 0.0002677 0.004598
35 PLASMA MEMBRANE REGION 38 929 0.0002947 0.004917
36 EXOCYTIC VESICLE 11 142 0.0003759 0.006098
37 AXON PART 14 219 0.0004635 0.007316
38 SITE OF POLARIZED GROWTH 11 149 0.0005656 0.008693
39 DENDRITE 22 451 0.000614 0.009194
40 ENDOCYTIC VESICLE MEMBRANE 11 152 0.0006685 0.009522
41 ENDOPLASMIC RETICULUM LUMEN 13 201 0.0006563 0.009522
42 PLASMA MEMBRANE RAFT 8 86 0.0007068 0.009828

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04150_mTOR_signaling_pathway 33 52 6.684e-42 1.203e-39
2 hsa04151_PI3K_AKT_signaling_pathway 39 351 1.807e-16 1.626e-14
3 hsa04510_Focal_adhesion 27 200 8.14e-14 4.884e-12
4 hsa04910_Insulin_signaling_pathway 19 138 2.931e-10 1.319e-08
5 hsa04014_Ras_signaling_pathway 24 236 8.17e-10 2.941e-08
6 hsa04914_Progesterone.mediated_oocyte_maturation 14 87 8.433e-09 2.53e-07
7 hsa04810_Regulation_of_actin_cytoskeleton 20 214 8.755e-08 2.251e-06
8 hsa04722_Neurotrophin_signaling_pathway 15 127 1.775e-07 3.993e-06
9 hsa04666_Fc_gamma_R.mediated_phagocytosis 13 95 2.082e-07 4.164e-06
10 hsa04960_Aldosterone.regulated_sodium_reabsorption 9 42 3.148e-07 5.667e-06
11 hsa04012_ErbB_signaling_pathway 12 87 5.607e-07 9.176e-06
12 hsa04010_MAPK_signaling_pathway 21 268 8.074e-07 1.211e-05
13 hsa04973_Carbohydrate_digestion_and_absorption 8 44 5.374e-06 7.441e-05
14 hsa04350_TGF.beta_signaling_pathway 10 85 2.087e-05 0.0002683
15 hsa04210_Apoptosis 10 89 3.131e-05 0.0003757
16 hsa04662_B_cell_receptor_signaling_pathway 9 75 4.602e-05 0.0005177
17 hsa04370_VEGF_signaling_pathway 9 76 5.117e-05 0.0005418
18 hsa04070_Phosphatidylinositol_signaling_system 9 78 6.296e-05 0.0006296
19 hsa04720_Long.term_potentiation 8 70 0.0001718 0.001628
20 hsa04390_Hippo_signaling_pathway 12 154 0.0001953 0.001757
21 hsa04630_Jak.STAT_signaling_pathway 12 155 0.0002074 0.001778
22 hsa04340_Hedgehog_signaling_pathway 7 56 0.0002494 0.002041
23 hsa04670_Leukocyte_transendothelial_migration 10 117 0.0003143 0.00246
24 hsa04062_Chemokine_signaling_pathway 13 189 0.000366 0.002745
25 hsa04664_Fc_epsilon_RI_signaling_pathway 8 79 0.0003983 0.002868
26 hsa04310_Wnt_signaling_pathway 11 151 0.0006326 0.004284
27 hsa04380_Osteoclast_differentiation 10 128 0.0006426 0.004284
28 hsa04360_Axon_guidance 10 130 0.0007253 0.004637
29 hsa04660_T_cell_receptor_signaling_pathway 9 108 0.0007471 0.004637
30 hsa04514_Cell_adhesion_molecules_.CAMs. 10 136 0.001028 0.006165
31 hsa04620_Toll.like_receptor_signaling_pathway 8 102 0.002141 0.01243
32 hsa04512_ECM.receptor_interaction 7 85 0.003043 0.01711
33 hsa04144_Endocytosis 11 203 0.006434 0.0351
34 hsa04140_Regulation_of_autophagy 4 34 0.006876 0.0364
35 hsa04916_Melanogenesis 7 101 0.007819 0.04021
36 hsa00562_Inositol_phosphate_metabolism 5 57 0.009045 0.04522
37 hsa04974_Protein_digestion_and_absorption 6 81 0.009853 0.04793
38 hsa04650_Natural_killer_cell_mediated_cytotoxicity 8 136 0.01193 0.05651
39 hsa04520_Adherens_junction 5 73 0.02429 0.1121
40 hsa04270_Vascular_smooth_muscle_contraction 6 116 0.04725 0.2126
41 hsa04920_Adipocytokine_signaling_pathway 4 68 0.06697 0.2878
42 hsa00531_Glycosaminoglycan_degradation 2 19 0.06714 0.2878
43 hsa04115_p53_signaling_pathway 4 69 0.06989 0.2926
44 hsa02010_ABC_transporters 3 44 0.07615 0.3115
45 hsa04710_Circadian_rhythm_._mammal 2 23 0.09374 0.3737
46 hsa04260_Cardiac_muscle_contraction 4 77 0.09551 0.3737
47 hsa00510_N.Glycan_biosynthesis 3 49 0.09778 0.3745
48 hsa00760_Nicotinate_and_nicotinamide_metabolism 2 24 0.1008 0.378
49 hsa04020_Calcium_signaling_pathway 7 177 0.1055 0.3877
50 hsa04114_Oocyte_meiosis 5 114 0.1148 0.4133
51 hsa04142_Lysosome 5 121 0.1377 0.4859
52 hsa03022_Basal_transcription_factors 2 37 0.2022 0.6998
53 hsa04145_Phagosome 5 156 0.275 0.9166
54 hsa00230_Purine_metabolism 5 162 0.3011 0.9508
55 hsa03320_PPAR_signaling_pathway 2 70 0.4694 1
56 hsa04730_Long.term_depression 2 70 0.4694 1
57 hsa04971_Gastric_acid_secretion 2 74 0.4986 1
58 hsa04110_Cell_cycle 3 128 0.5524 1
59 hsa04640_Hematopoietic_cell_lineage 2 88 0.5922 1
60 hsa04970_Salivary_secretion 2 89 0.5984 1
61 hsa04540_Gap_junction 2 90 0.6044 1
62 hsa04120_Ubiquitin_mediated_proteolysis 3 139 0.6083 1
63 hsa04972_Pancreatic_secretion 2 101 0.6669 1
64 hsa03013_RNA_transport 3 152 0.6682 1
65 hsa04530_Tight_junction 2 133 0.8041 1
66 hsa04141_Protein_processing_in_endoplasmic_reticulum 2 168 0.8946 1

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1275;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-224-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-374b-3p;hsa-miR-421;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-486-5p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-592;hsa-miR-629-5p;hsa-miR-940 31 IGF1 Sponge network -0.18 0.69284 -0.306 0.46681 0.587
2

EMX2OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-1275;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-374b-5p;hsa-miR-421;hsa-miR-424-5p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-502-5p;hsa-miR-505-3p;hsa-miR-548o-3p;hsa-miR-577;hsa-miR-663b;hsa-miR-93-5p 27 AKT3 Sponge network -0.18 0.69284 -0.591 0.01641 0.542
3

CECR7

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-1275;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-320a;hsa-miR-33a-3p;hsa-miR-361-5p;hsa-miR-362-5p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-592;hsa-miR-629-5p;hsa-miR-940 28 IGF1 Sponge network -1.094 0.00665 -0.306 0.46681 0.513
4

CECR7

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-1275;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-28-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-320a;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-362-5p;hsa-miR-501-3p;hsa-miR-502-3p;hsa-miR-502-5p;hsa-miR-93-5p 22 AKT3 Sponge network -1.094 0.00665 -0.591 0.01641 0.508
5

MIAT

 hsa-miR-130b-3p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-301a-3p;hsa-miR-362-5p;hsa-miR-374b-3p;hsa-miR-421;hsa-miR-452-5p;hsa-miR-454-3p 11 IGF1 Sponge network -0.213 0.41989 -0.306 0.46681 0.431
6

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-320c;hsa-miR-335-3p;hsa-miR-362-5p;hsa-miR-577;hsa-miR-663b;hsa-miR-93-5p 18 AKT3 Sponge network -0.092 0.73537 -0.591 0.01641 0.405
7

MEG3

 hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-32-3p;hsa-miR-362-5p;hsa-miR-374b-3p;hsa-miR-576-5p;hsa-miR-577 16 IGF1 Sponge network -0.092 0.73537 -0.306 0.46681 0.37
8

CECR7

 hsa-let-7f-1-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-32-3p;hsa-miR-335-5p;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-590-5p 11 PIK3CA Sponge network -1.094 0.00665 -0.14 0.20578 0.368
9

CECR7

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-23a-3p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-5p;hsa-miR-30c-5p;hsa-miR-32-3p;hsa-miR-331-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-93-5p 35 PRKAA2 Sponge network -1.094 0.00665 -0.648 0.2102 0.309
10

ZNF883

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-20a-5p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-320a;hsa-miR-320c;hsa-miR-335-3p;hsa-miR-33a-3p 13 AKT3 Sponge network -0.43 0.25905 -0.591 0.01641 0.3
11

EMX2OS

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-106b-5p;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-144-3p;hsa-miR-146a-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-26a-1-3p;hsa-miR-26a-2-3p;hsa-miR-26b-5p;hsa-miR-30e-3p;hsa-miR-32-3p;hsa-miR-331-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-34a-5p;hsa-miR-374a-3p;hsa-miR-576-5p;hsa-miR-577;hsa-miR-590-3p;hsa-miR-7-1-3p;hsa-miR-93-5p 39 PRKAA2 Sponge network -0.18 0.69284 -0.648 0.2102 0.292
12

HCG11

 hsa-let-7a-3p;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-186-5p;hsa-miR-26b-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p 10 IGF1 Sponge network 0.395 0.14374 -0.306 0.46681 0.271
13

EMX2OS

 hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-192-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-21-3p;hsa-miR-26b-5p;hsa-miR-335-5p;hsa-miR-378a-3p;hsa-miR-532-3p;hsa-miR-592;hsa-miR-760;hsa-miR-93-3p 15 RPS6KA2 Sponge network -0.18 0.69284 -0.617 0.00159 0.27
14

ZNF883

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-101-5p;hsa-miR-130b-3p;hsa-miR-148a-5p;hsa-miR-15b-3p;hsa-miR-186-5p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-26b-5p;hsa-miR-27a-3p;hsa-miR-29a-3p;hsa-miR-29b-3p;hsa-miR-301a-3p;hsa-miR-320a;hsa-miR-33a-3p;hsa-miR-576-5p 19 IGF1 Sponge network -0.43 0.25905 -0.306 0.46681 0.269
15

HCG11

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-10a-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-146a-5p;hsa-miR-146b-5p;hsa-miR-15b-3p;hsa-miR-16-2-3p;hsa-miR-186-5p;hsa-miR-200a-3p;hsa-miR-21-3p;hsa-miR-26a-1-3p;hsa-miR-26b-5p;hsa-miR-338-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-7-1-3p 22 PRKAA2 Sponge network 0.395 0.14374 -0.648 0.2102 0.258
16

CECR7

 hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-192-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-26b-5p;hsa-miR-30b-5p;hsa-miR-30d-5p;hsa-miR-335-5p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-532-3p;hsa-miR-592;hsa-miR-760 16 RPS6KA2 Sponge network -1.094 0.00665 -0.617 0.00159 0.258
17

EMX2OS

 hsa-let-7f-1-3p;hsa-miR-148a-5p;hsa-miR-148b-3p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-32-3p;hsa-miR-335-5p;hsa-miR-339-5p;hsa-miR-374b-5p;hsa-miR-576-5p;hsa-miR-582-3p;hsa-miR-590-3p 13 PIK3CA Sponge network -0.18 0.69284 -0.14 0.20578 0.254
18

DGCR5

 hsa-let-7f-1-3p;hsa-let-7g-5p;hsa-miR-141-3p;hsa-miR-146a-5p;hsa-miR-15b-3p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-3p;hsa-miR-26a-2-3p;hsa-miR-30c-5p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-33a-3p;hsa-miR-576-5p 21 PRKAA2 Sponge network 0.389 0.26887 -0.648 0.2102 0.251

Quest ID: 1b1281d24d6f66f6829f0a93acaa8dce